Chapter 4 The Melanocortin-1 Receptor Gene Polymorphism and Association with Human Skin Cancer

Progress in Molecular Biology and Translational Science

Volumn 88, Issue C, 2009, Pages 85-153

  Beaumont, Kimberley A ^a   Liu, Yan Yan ^a   Sturm, Richard A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOCORTIN 1 RECEPTOR;

CHEMISTRY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; METABOLISM; PHENOTYPE; PIGMENTATION; REVIEW; SKIN TUMOR;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; PHENOTYPE; PIGMENTATION; POLYMORPHISM, GENETIC; RECEPTOR, MELANOCORTIN, TYPE 1; SKIN NEOPLASMS;

EID: 77957056141     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-1173(09)88004-6     Document Type: Review

References (440)

1. Brenner M., and Hearing V.J. The protective role of melanin against UV damage in human skin. Photochem Photobiol 84 (2008) 539-549
2. Bliss J.M., Ford D., Swerdlow A.J., Armstrong B.K., Cristofolini M., Elwood J.M., et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE). Int J Cancer 62 (1995) 367-376
3. Davenport G., and Davenport C. Heredity of hair color in man. Am Nat 43 (1909) 193-211
4. Sturm R.A., Box N.F., and Ramsay M. Human pigmentation genetics: the difference is only skin deep. Bioessays 20 (1998) 712-721
5. Hinds D.A., Stuve L.L., Nilsen G.B., Halperin E., Eskin E., Ballinger D.G., et al. Whole-genome patterns of common DNA variation in three human populations. Science 307 (2005) 1072-1079
6. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449 (2007) 851-861
7. Valverde P., Healy E., Jackson I., Rees J.L., and Thody A.J. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 11 (1995) 328-330
8. Box N.F., Wyeth J.R., O'Gorman L.E., Martin N.G., and Sturm R.A. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum Mol Genet 6 (1997) 1891-1897
9. Smith R., Healy E., Siddiqui S., Flanagan N., Steijlen P.M., Rosdahl I., et al. Melanocortin 1 receptor variants in an Irish population. J Invest Dermatol 111 (1998) 119-122
10. Leiter U., and Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer-the role of sunlight. Adv Exp Med Biol 624 (2008) 89-103
11. MacLennan R., Green A.C., McLeod G.R., and Martin N.G. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 84 (1992) 1427-1432
12. Diepgen T.L., and Mahler V. The epidemiology of skin cancer. Br J Dermatol 146 Suppl. 61 (2002) 1-6
13. Sturm R.A. Skin color and skin cancer-MC1R, the genetic link. Melanoma Res 12 (2002) 405-416
14. Thomas A.J., and Erickson C.A. The making of a melanocyte: the specification of melanoblasts from the neural crest. Pigment Cell Melanoma Res 21 (2008) 598-610
15. Raposo G., and Marks M.S. Melanosomes-dark organelles enlighten endosomal membrane transport. Nat Rev Mol Cell Biol 8 (2007) 786-797
16. Seabra M.C., and Coudrier E. Rab GTPases and myosin motors in organelle motility. Traffic 5 (2004) 393-399
17. Pastural E., Barrat F.J., Dufourcq-Lagelouse R., Certain S., Sanal O., Jabado N., et al. Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nat Genet 16 (1997) 289-292
18. Menasche G., Pastural E., Feldmann J., Certain S., Ersoy F., Dupuis S., et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet 25 (2000) 173-176
19. Menasche G., Ho C.H., Sanal O., Feldmann J., Tezcan I., Ersoy F., et al. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). J Clin Invest 112 (2003) 450-456
20. Tsatmali M., Ancans J., and Thody A.J. Melanocyte function and its control by melanocortin peptides. J Histochem Cytochem 50 (2002) 125-133
21. Van Den Bossche K., Naeyaert J.M., and Lambert J. The quest for the mechanism of melanin transfer. Traffic 7 (2006) 769-778
22. Hach P., Borovansky J., and Vedralova E. Melanosome-a sophisticated organelle. Sb Lek 94 (1993) 113-123
23. Hill H.Z. The function of melanin or six blind people examine an elephant. Bioessays 14 (1992) 49-56
24. Futter C.E. The molecular regulation of organelle transport in mammalian retinal pigment epithelial cells. Pigment Cell Res 19 (2006) 104-111
25. Maddodi N., and Setaluri V. Role of UV in cutaneous melanoma. Photochem Photobiol 84 (2008) 528-536
26. Sato C., Ito S., and Takeuchi T. Establishment of a mouse melanocyte clone which synthesizes both eumelanin and pheomelanin. Cell Struct Funct 10 (1985) 421-425
27. Thong H.Y., Jee S.H., Sun C.C., and Boissy R.E. The patterns of melanosome distribution in keratinocytes of human skin as one determining factor of skin color. Br J Dermatol 149 (2003) 498-505
28. Quevedo W.C., and Holstein T.J. General biology of mammalian pigmentation. In: Nordlund J.J. (Ed). The pigmentary system: physiology and pathophysiology (2006), Blackwell Publisher, Malden, MA 63-90
29. Szabo G., Gerald A.B., Pathak M.A., and Fitzpatrick T.B. Racial differences in the fate of melanosomes in human epidermis. Nature 222 (1969) 1081-1082
30. Toda K., Pathak M.A., Parrish J.A., Fitzpatrick T.B., and Quevedo W.C. Alteration of racial differences in melanosome distribution in human epidermis after exposure to ultraviolet light. Nat New Biol 236 (1972) 143-145
31. Montagna W., and Carlisle K. The architecture of black and white facial skin. J Am Acad Dermatol 24 (1991) 929-937
32. Montagna W., Prota G., and Kenney J.A. Black skin structure and function (1993), Academic Press, New York
33. Halder R.M., and Bridgeman-Shah S. Skin cancer in African Americans. Cancer 75 (1995) 667-673
34. Fitzpatrick T.B. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 124 (1988) 869-871
35. Vincensi M.R., d'Ischia M., Napolitano A., Procaccini E.M., Riccio G., Monfrecola G., et al. Phaeomelanin versus eumelanin as a chemical indicator of ultraviolet sensitivity in fair-skinned subjects at high risk for melanoma: a pilot study. Melanoma Res 8 (1998) 53-58
36. Menon I.A., Persad S., Haberman H.F., and Kurian C.J. A comparative study of the physical and chemical properties of melanins isolated from human black and red hair. J Invest Dermatol 80 (1983) 202-206
37. Nappi A.J., and Vass E. Hydrogen peroxide generation associated with the oxidations of the eumelanin precursors 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid. Melanoma Res 6 (1996) 341-349
38. Takeuchi S., Zhang W., Wakamatsu K., Ito S., Hearing V.J., Kraemer K.H., et al. Melanin acts as a potent UVB photosensitizer to cause an atypical mode of cell death in murine skin. Proc Natl Acad Sci USA 101 (2004) 15076-15081
39. Ranadive N.S., Shirwadkar S., Persad S., and Menon I.A. Effects of melanin-induced free radicals on the isolated rat peritoneal mast cells. J Invest Dermatol 86 (1986) 303-307
40. Raposo G., and Marks M.S. The dark side of lysosome-related organelles: specialization of the endocytic pathway for melanosome biogenesis. Traffic 3 (2002) 237-248
41. Maul G.G. Golgi-melanosome relationship in human melanoma in vitro. J Ultrastruct Res 26 (1969) 163-176
42. Berson J.F., Harper D.C., Tenza D., Raposo G., and Marks M.S. Pmel17 initiates premelanosome morphogenesis within multivesicular bodies. Mol Biol Cell 12 (2001) 3451-3464
43. Theos A.C., Truschel S.T., Raposo G., and Marks M.S. The Silver locus product Pmel17/gp100/Silv/ME20: controversial in name and in function. Pigment Cell Res 18 (2005) 322-336
44. Raposo G., Tenza D., Murphy D.M., Berson J.F., and Marks M.S. Distinct protein sorting and localization to premelanosomes, melanosomes, and lysosomes in pigmented melanocytic cells. J Cell Biol 152 (2001) 809-824
45. Ito S., and Wakamatsu K. Chemistry of mixed melanogenesis-pivotal roles of dopaquinone. Photochem Photobiol 84 (2008) 582-592
46. Kushimoto T., Valencia J.C., Costin G.E., Toyofuku K., Watabe H., Yasumoto K.I., et al. The melanosome: an ideal model to study cellular differentiation. Pigment Cell Res 16 (2003) 237
47. Liu Y., Hong L., Wakamatsu K., Ito S., Adhyaru B., Cheng C.Y., et al. Comparison of structural and chemical properties of black and red human hair melanosomes. Photochem Photobiol 81 (2005) 135-144
48. Furumura M., Sakai C., Potterf S.B., Vieira W.D., Barsh G.S., and Hearing V.J. Characterization of genes modulated during pheomelanogenesis using differential display. Proc Natl Acad Sci USA 95 (1998) 7374-7378
49. Leonard J.H., Marks L.H., Chen W., Cook A.L., Boyle G.M., Smit D.J., et al. Screening of human primary melanocytes of defined melanocortin-1 receptor genotype: pigmentation marker, ultrastructural and UV-survival studies. Pigment Cell Res 16 (2003) 198-207
50. Seiji M., Shimao K., Birbeck M.S., and Fitzpatrick T.B. Subcellular localization of melanin biosynthesis. Ann N Y Acad Sci 100 (1963) 497-533
51. Kwon B.S., Haq A.K., Pomerantz S.H., and Halaban R. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc Natl Acad Sci USA 84 (1987) 7473-7477
52. Oetting W.S., and King R.A. Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism. Hum Mutat 13 (1999) 99-115
53. Frudakis T., Thomas M., Gaskin Z., Venkateswarlu K., Chandra K.S., Ginjupalli S., et al. Sequences associated with human iris pigmentation. Genetics 165 (2003) 2071-2083
54. Shriver M.D., Parra E.J., Dios S., Bonilla C., Norton H., Jovel C., et al. Skin pigmentation, biogeographical ancestry and admixture mapping. Hum Genet 112 (2003) 387-399
55. Sulem P., Gudbjartsson D.F., Stacey S.N., Helgason A., Rafnar T., Magnusson K.P., et al. Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat Genet 39 (2007) 1443-1452
56. Gudbjartsson D.F., Sulem P., Stacey S.N., Goldstein A.M., Rafnar T., Sigurgeirsson B., et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 40 (2008) 886-891
57. Huizing M., Sarangarajan R., Strovel E., Zhao Y., Gahl W.A., and Boissy R.E. AP-3 mediates tyrosinase but not TRP-1 trafficking in human melanocytes. Mol Biol Cell 12 (2001) 2075-2085
58. Dell'Angelica E.C., Shotelersuk V., Aguilar R.C., Gahl W.A., and Bonifacino J.S. Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol Cell 3 (1999) 11-21
59. Wei M.L. Hermansky-Pudlak syndrome: a disease of protein trafficking and organelle function. Pigment Cell Res 19 (2006) 19-42
60. Theos A.C., Tenza D., Martina J.A., Hurbain I., Peden A.A., Sviderskaya E.V., et al. Functions of adaptor protein (AP)-3 and AP-1 in tyrosinase sorting from endosomes to melanosomes. Mol Biol Cell 16 (2005) 5356-5372
61. Chi A., Valencia J.C., Hu Z.Z., Watabe H., Yamaguchi H., Mangini N.J., et al. Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes. J Proteome Res 5 (2006) 3135-3144
62. Cohen T., Muller R.M., Tomita Y., and Shibahara S. Nucleotide sequence of the cDNA encoding human tyrosinase-related protein. Nucleic Acids Res 18 (1990) 2807-2808
63. Jackson I.J., Chambers D.M., Tsukamoto K., Copeland N.G., Gilbert D.J., Jenkins N.A., et al. A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus. EMBO J 11 (1992) 527-535
64. Jackson I.J. Molecular and developmental genetics of mouse coat color. Annu Rev Genet 28 (1994) 189-217
65. Boissy R.E., Zhao H., Oetting W.S., Austin L.M., Wildenberg S.C., Boissy Y.L., et al. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3". Am J Hum Genet 58 (1996) 1145-1156
66. Manga P., Kromberg J.G., Box N.F., Sturm R.A., Jenkins T., and Ramsay M. Rufous oculocutaneous albinism in southern African Blacks is caused by mutations in the TYRP1 gene. Am J Hum Genet 61 (1997) 1095-1101
67. Myles S., Somel M., Tang K., Kelso J., and Stoneking M. Identifying genes underlying skin pigmentation differences among human populations. Hum Genet 120 (2007) 613-621
68. Pawelek J.M. After dopachrome?. Pigment Cell Res 4 (1991) 53-62
69. Jimenez-Cervantes C., Solano F., Kobayashi T., Urabe K., Hearing V.J., Lozano J.A., et al. A new enzymatic function in the melanogenic pathway. The 5,6-dihydroxyindole-2-carboxylic acid oxidase activity of tyrosinase-related protein-1 (TRP1). J Biol Chem 269 (1994) 17993-18000
70. Hearing V.J., Tsukamoto K., Urabe K., Kameyama K., Montague P.M., and Jackson I.J. Functional properties of cloned melanogenic proteins. Pigment Cell Res 5 (1992) 264-270
71. Kobayashi T., Urabe K., Winder A., Tsukamoto K., Brewington T., Imokawa G., et al. DHICA oxidase activity of TRP1 and interactions with other melanogenic enzymes. Pigment Cell Res 7 (1994) 227-234
72. Winder A., Kobayashi T., Tsukamoto K., Urabe K., Aroca P., Kameyama K., et al. The tyrosinase gene family-interactions of melanogenic proteins to regulate melanogenesis. Cell Mol Biol Res 40 (1994) 613-626
73. Kobayashi T., and Hearing V.J. Direct interaction of tyrosinase with Tyrp1 to form heterodimeric complexes in vivo. J Cell Sci 120 (2007) 4261-4268
74. Kushimoto T., Basrur V., Valencia J., Matsunaga J., Vieira W.D., Ferrans V.J., et al. A model for melanosome biogenesis based on the purification and analysis of early melanosomes. Proc Natl Acad Sci USA 98 (2001) 10698-10703
75. Marks M.S., Theos A.C., and Raposo G. Melanosomes and MHC class II antigen-processing compartments: a tinted view of intracellular trafficking and immunity. Immunol Res 27 (2003) 409-426
76. Setty S.R., Tenza D., Truschel S.T., Chou E., Sviderskaya E.V., Theos A.C., et al. BLOC-1 is required for cargo-specific sorting from vacuolar early endosomes toward lysosome-related organelles. Mol Biol Cell 18 (2007) 768-780
77. Theos A.C., Berson J.F., Theos S.C., Herman K.E., Harper D.C., Tenza D., et al. Dual loss of ER export and endocytic signals with altered melanosome morphology in the silver mutation of Pmel17. Mol Biol Cell 17 (2006) 3598-3612
78. Berson J.F., Theos A.C., Harper D.C., Tenza D., Raposo G., and Marks M.S. Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesis. J Cell Biol 161 (2003) 521-533
79. Dunn L.C., and Thigpen L.W. The silver mouse-a recessive color variation. J Heredity 21 (1930) 495-498
80. Reissmann M., Bierwolf J., and Brockmann G.A. Two SNPs in the SILV gene are associated with silver coat color in ponies. Anim Genet 38 (2007) 1-6
81. Clark L.A., Wahl J.M., Rees C.A., and Murphy K.E. Retrotransposon insertion in SILV is responsible for merle patterning of the domestic dog. Proc Natl Acad Sci USA 103 (2006) 1376-1381
82. Gardner J.M., Nakatsu Y., Gondo Y., Lee S., Lyon M.F., King R.A., et al. The mouse pink-eyed dilution gene: association with human Prader-Willi and Angelman syndromes. Science 257 (1992) 1121-1124
83. Rinchik E.M., Bultman S.J., Horsthemke B., Lee S.T., Strunk K.M., Spritz R.A., et al. A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism. Nature 361 (1993) 72-76
84. Lao O., de Gruijter J.M., van Duijn K., Navarro A., and Kayser M. Signatures of positive selection in genes associated with human skin pigmentation as revealed from analyses of single nucleotide polymorphisms. Ann Hum Genet 71 (2007) 354-369
85. Duffy D.L., Montgomery G.W., Chen W., Zhao Z.Z., Le L., James M.R., et al. A three-single-nucleotide polymorphism haplotype in intron 1 of OCA2 explains most human eye-color variation. Am J Hum Genet 80 (2007) 241-252
86. Norton H.L., Kittles R.A., Parra E., McKeigue P., Mao X., Cheng K., et al. Genetic evidence for the convergent evolution of light skin in Europeans and East Asians. Mol Biol Evol 24 (2007) 710-722
87. Eiberg H., Troelsen J., Nielsen M., Mikkelsen A., Mengel-From J., Kjaer K.W., et al. Blue eye color in humans may be caused by a perfectly associated founder mutation in a regulatory element located within the HERC2 gene inhibiting OCA2 expression. Hum Genet 123 (2008) 177-187
88. Sturm R.A., Duffy D.L., Zhao Z.Z., Leite F.P., Stark M.S., Hayward N.K., et al. A single SNP in an evolutionary conserved region within intron 86 of the HERC2 gene determines human blue-brown eye color. Am J Hum Genet 82 (2008) 424-431
89. Puri N., Gardner J.M., and Brilliant M.H. Aberrant pH of melanosomes in pink-eyed dilution (p) mutant melanocytes. J Invest Dermatol 115 (2000) 607-613
90. Sitaram A., Piccirillo R., Palmisano I., Harper D.C., Dell'angelica E.C., Schiaffino M.V., et al. Localization to mature melanosomes by virtue of cytoplasmic dileucine motifs is required for human OCA2 function. Mol Biol Cell 20 (2009) 1464-1477
91. Brilliant M.H. The mouse p (pink-eyed dilution) and human P genes, oculocutaneous albinism type 2 (OCA2), and melanosomal pH. Pigment Cell Res 14 (2001) 86-93
92. Toyofuku K., Valencia J.C., Kushimoto T., Costin G.E., Virador V.M., Vieira W.D., et al. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase. Pigment Cell Res 15 (2002) 217-224
93. Oetting W.S., Garrett S.S., Brott M., and King R.A. P gene mutations associated with oculocutaneous albinism type II (OCA2). Hum Mutat 25 (2005) 323
94. Newton J.M., Cohen-Barak O., Hagiwara N., Gardner J.M., Davisson M.T., King R.A., et al. Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4. Am J Hum Genet 69 (2001) 981-988
95. Graf J., Hodgson R., and van Daal A. Single nucleotide polymorphisms in the MATP gene are associated with normal human pigmentation variation. Hum Mutat 25 (2005) 278-284
96. Graf J., Voisey J., Hughes I., and van Daal A. Promoter polymorphisms in the MATP (SLC45A2) gene are associated with normal human skin color variation. Hum Mutat 28 (2007) 710-717
97. Smith D.R., Spaulding D.T., Glenn H.M., and Fuller B.B. The relationship between Na(+)/H(+) exchanger expression and tyrosinase activity in human melanocytes. Exp Cell Res 298 (2004) 521-534
98. Lamason R.L., Mohideen M.A., Mest J.R., Wong A.C., Norton H.L., Aros M.C., et al. SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans. Science 310 (2005) 1782-1786
99. Ginger R.S., Askew S.E., Ogborne R.M., Wilson S., Ferdinando D., Dadd T., et al. SLC24A5 encodes a trans-Golgi network protein with potassium-dependent sodium-calcium exchange activity that regulates human epidermal melanogenesis. J Biol Chem 283 (2008) 5486-5496
100. Han J., Kraft P., Nan H., Guo Q., Chen C., Qureshi A., et al. A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet 4 (2008) e1000074
101. Sulem P., Gudbjartsson D.F., Stacey S.N., Helgason A., Rafnar T., Jakobsdottir M., et al. Two newly identified genetic determinants of pigmentation in Europeans. Nat Genet 40 (2008) 835-837
102. Hoek K.S., Schlegel N.C., Eichhoff O.M., Widmer D.S., Praetorius C., Einarsson S.O., et al. Novel MITF targets identified using a two-step DNA microarray strategy. Pigment Cell Melanoma Res 21 (2008) 665-676
103. Tassabehji M., Newton V.E., and Read A.P. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet 8 (1994) 251-255
104. Duffy D.L., Zhao Z.Z., Sturm R.A., Hayward N.K., Martin N.G., and Montgomery G.W. Multiple pigmentation gene polmorphisms account for a substantial proportion of risk of cutaneous malignant melanoma. J Invest Dermatol (2009) [in press]
105. Sundram U., Harvell J.D., Rouse R.V., and Natkunam Y. Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA. Mod Pathol 16 (2003) 802-810
106. Wehrle-Haller B. The role of Kit-ligand in melanocyte development and epidermal homeostasis. Pigment Cell Res 16 (2003) 287-296
107. Hou L., and Pavan W.J. Transcriptional and signaling regulation in neural crest stem cell-derived melanocyte development: do all roads lead to Mitf?. Cell Res 18 (2008) 1163-1176
108. Giebel L.B., and Spritz R.A. Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci USA 88 (1991) 8696-8699
109. Miller C.T., Beleza S., Pollen A.A., Schluter D., Kittles R.A., Shriver M.D., et al. cis-Regulatory changes in Kit ligand expression and parallel evolution of pigmentation in sticklebacks and humans. Cell 131 (2007) 1179-1189
110. Oetting W., Montoliu L., and Bennet D. color genes (2009), European Society for Pigment Cell Research. http://www.espcr.org/micemut World Wide Web
111. Price E.R., Horstmann M.A., Wells A.G., Weilbaecher K.N., Takemoto C.M., Landis M.W., et al. Alpha-melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J Biol Chem 273 (1998) 33042-33047
112. Busca R., and Ballotti R. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res 13 (2000) 60-69
113. Bertolotto C., Abbe P., Hemesath T.J., Bille K., Fisher D.E., Ortonne J.P., et al. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol 142 (1998) 827-835
114. Bertolotto C., Bille K., Ortonne J.P., and Ballotti R. Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product. J Cell Biol 134 (1996) 747-755
115. Bertolotto C., Busca R., Abbe P., Bille K., Aberdam E., Ortonne J.P., et al. Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol 18 (1998) 694-702
116. Chiaverini C., Beuret L., Flori E., Busca R., Abbe P., Bille K., et al. Microphthalmia-associated transcription factor regulates RAB27A gene expression and controls melanosome transport. J Biol Chem 283 (2008) 12635-12642
117. Passeron T., Bahadoran P., Bertolotto C., Chiaverini C., Busca R., Valony G., et al. Cyclic AMP promotes a peripheral distribution of melanosomes and stimulates melanophilin/Slac2-a and actin association. FASEB J 18 (2004) 989-991
118. Du J., Miller A.J., Widlund H.R., Horstmann M.A., Ramaswamy S., and Fisher D.E. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. Am J Pathol 163 (2003) 333-343
119. Du J., and Fisher D.E. Identification of Aim-1 as the underwhite mouse mutant and its transcriptional regulation by MITF. J Biol Chem 277 (2002) 402-406
120. Adachi S., Morii E., Kim D.K., Ogihara H., Jippo T., Ito A., et al. Involvement of mi-transcription factor in expression of alpha-melanocyte-stimulating hormone receptor in cultured mast cells of mice. J Immunol 164 (2000) 855
121. Aoki H., and Moro O. Involvement of microphthalmia-associated transcription factor (MITF) in expression of human melanocortin-1 receptor (MC1R). Life Sci 71 (2002) 2171-2179
122. Kobayashi N., Nakagawa A., Muramatsu T., Yamashina Y., Shirai T., Hashimoto M.W., et al. Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis. J Invest Dermatol 110 (1998) 806-810
123. Rass K., and Reichrath J. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer. Adv Exp Med Biol 624 (2008) 162-178
124. Cadle R.D., and Allen E.R. Atmospheric photochemistry. Science 167 (1970) 243-249
125. Bennett D.C. Ultraviolet wavebands and melanoma initiation. Pigment Cell Melanoma Res 21 (2008) 520-524
126. Vink A.A., and Roza L. Biological consequences of cyclobutane pyrimidine dimers. J Photochem Photobiol 65 (2001) 101-104
127. Kvam E., and Tyrrell R.M. Induction of oxidative DNA base damage in human skin cells by UV and near visible radiation. Carcinogenesis 18 (1997) 2379-2384
128. Peak J.G., and Peak M.J. Comparison of initial yields of DNA-to-protein crosslinks and single-strand breaks induced in cultured human cells by far- and near-ultraviolet light, blue light and X-rays. Mutat Res 246 (1991) 187-191
129. Douki T., Reynaud-Angelin A., Cadet J., and Sage E. Bipyrimidine photoproducts rather than oxidative lesions are the main type of DNA damage involved in the genotoxic effect of solar UVA radiation. Biochemistry 42 (2003) 9221-9226
130. Mouret S., Baudouin C., Charveron M., Favier A., Cadet J., and Douki T. Cyclobutane pyrimidine dimers are predominant DNA lesions in whole human skin exposed to UVA radiation. Proc Natl Acad Sci USA 103 (2006) 13765-13770
131. Chadwick C.A., Potten C.S., Nikaido O., Matsunaga T., Proby C., and Young A.R. The detection of cyclobutane thymine dimers, (6-4) photolesions and the Dewar photoisomers in sections of UV-irradiated human skin using specific antibodies, and the demonstration of depth penetration effects. J Photochem Photobiol 28 (1995) 163-170
132. Halliday G.M. Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mutat Res 571 (2005) 107-120
133. Lavker R.M., Gerberick G.F., Veres D., Irwin C.J., and Kaidbey K.H. Cumulative effects from repeated exposures to suberythemal doses of UVB and UVA in human skin. J Am Acad Dermatol 32 (1995) 53-62
134. Hadley M.E., Heward C.B., Hruby V.J., Sawyer T.K., and Yang Y.C. Biological actions of melanocyte-stimulating hormone. Ciba Found Symp 81 (1981) 244-262
135. Pawelek J.M. Factors regulating growth and pigmentation of melanoma cells. J Invest Dermatol 66 (1976) 201-209
136. Mountjoy K.G., Robbins L.S., Mortrud M.T., and Cone R.D. The cloning of a family of genes that encode the melanocortin receptors. Science 257 (1992) 1248-1251
137. Chhajlani V., and Wikberg J.E. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 309 (1992) 417-420
138. Roberts D.W., Newton R.A., Beaumont K.A., Helen Leonard J., and Sturm R.A. Quantitative analysis of MC1R gene expression in human skin cell cultures. Pigment Cell Res 19 (2006) 76-89
139. Roberts D.W., Newton R.A., and Sturm R.A. MC1R expression in skin: is it confined to melanocytes?. J Invest Dermatol 127 (2007) 2472-2473
140. Li L., Hu D.N., Zhao H., McCormick S.A., Nordlund J.J., and Boissy R.E. Uveal melanocytes do not respond to or express receptors for alpha-melanocyte-stimulating hormone. Invest Ophthalmol Visual Sci 47 (2006) 4507-4512
141. Cone R.D., Mountjoy K.G., Robbins L.S., Nadeau J.H., Johnson K.R., Roselli-Rehfuss L., et al. Cloning and functional characterization of a family of receptors for the melanotropic peptides. Ann N Y Acad Sci 680 (1993) 342-363
142. Searle A.G. An extension series in the mouse. J Heredity 59 (1968) 341-342
143. Robbins L.S., Nadeau J.H., Johnson K.R., Kelly M.A., Roselli-Rehfuss L., Baack E., et al. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72 (1993) 827-834
144. Jackson I.J. Molecular genetics. Color-coded switches. Nature 362 (1993) 587-588
145. Lerner A.B., and McGuire J.S. Effect of alpha- and beta-melanocyte stimulating hormones on the skin color of man. Nature 189 (1961) 176-179
146. Halaban R., Pomerantz S.H., Marshall S., Lambert D.T., and Lerner A.B. Regulation of tyrosinase in human melanocytes grown in culture. J Cell Biol 97 (1983) 480-488
147. Ranson M., Posen S., and Mason R.S. Human melanocytes as a target tissue for hormones: in vitro studies with 1 alpha-25, dihydroxyvitamin D3, alpha-melanocyte stimulating hormone, and beta-estradiol. J Invest Dermatol 91 (1988) 593-598
148. Friedmann P.S., Wren F., Buffey J., and Macneil S. Alpha-MSH causes a small rise in cAMP but has no effect on basal or ultraviolet-stimulated melanogenesis in human melanocytes. Br J Dermatol 123 (1990) 145-151
149. Hunt G., Todd C., Cresswell J.E., and Thody A.J. Alpha-melanocyte stimulating hormone and its analogue Nle4DPhe7 alpha-MSH affect morphology, tyrosinase activity and melanogenesis in cultured human melanocytes. J Cell Sci 107 (1994) 205-211
150. Hunt G., Kyne S., Wakamatsu K., Ito S., and Thody A.J. Nle4DPhe7 alpha-melanocyte-stimulating hormone increases the eumelanin:phaeomelanin ratio in cultured human melanocytes. J Invest Dermatol 104 (1995) 83-85
151. Levine N., Sheftel S.N., Eytan T., Dorr R.T., Hadley M.E., Weinrach J.C., et al. Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin. JAMA 266 (1991) 2730-2736
152. Fitzgerald L.M., Fryer J.L., Dwyer T., and Humphrey S.M. Effect of MELANOTAN, [Nle(4), D-Phe(7)]-alpha-MSH, on melanin synthesis in humans with MC1R variant alleles. Peptides 27 (2006) 388-394
153. Arlt W., and Allolio B. Adrenal insufficiency. Lancet 361 (2003) 1881-1893
154. Chakraborty A.K., Funasaka Y., Slominski A., Ermak G., Hwang J., Pawelek J.M., et al. Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim Biophys Acta 1313 (1996) 130-138
155. Wintzen M., Yaar M., Burbach J.P., and Gilchrest B.A. Proopiomelanocortin gene product regulation in keratinocytes. J Invest Dermatol 106 (1996) 673-678
156. Wintzen M., and Gilchrest B.A. Proopiomelanocortin, its derived peptides, and the skin. J Invest Dermatol 106 (1996) 3-10
157. Rousseau K., Kauser S., Pritchard L.E., Warhurst A., Oliver R.L., Slominski A., et al. Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis. FASEB J 21 (2007) 1844-1856
158. De Luca M., Siegrist W., Bondanza S., Mathor M., Cancedda R., and Eberle A.N. Alpha melanocyte stimulating hormone (alpha MSH) stimulates normal human melanocyte growth by binding to high-affinity receptors. J Cell Sci 105 (1993) 1079-1084
159. Abdel-Malek Z., Swope V.B., Suzuki I., Akcali C., Harriger M.D., Boyce S.T., et al. Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc Natl Acad Sci USA 92 (1995) 1789-1793
160. Abdel-Malek Z., Scott M.C., Suzuki I., Tada A., Im S., Lamoreux L., et al. The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation. Pigment Cell Res 13 (2000) 156-162
161. Virador V.M., Muller J., Wu X., Abdel-Malek Z.A., Yu Z.X., Ferrans V.J., et al. Influence of alpha-melanocyte-stimulating hormone and ultraviolet radiation on the transfer of melanosomes to keratinocytes. FASEB J 16 (2002) 105-107
162. Gilchrest B.A., and Eller M.S. The tale of the telomere: implications for prevention and treatment of skin cancers. J Invest Dermatol 10 (2005) 124-130
163. Khlgatian M.K., Hadshiew I.M., Asawanonda P., Yaar M., Eller M.S., Fujita M., et al. Tyrosinase gene expression is regulated by p53. J Invest Dermatol 118 (2002) 126-132
164. Cui R., Widlund H.R., Feige E., Lin J.Y., Wilensky D.L., Igras V.E., et al. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 128 (2007) 853-864
165. Box N.F., and Terzian T. The role of p53 in pigmentation, tanning and melanoma. Pigment Cell Melanoma Res 21 (2008) 525-533
166. Sakai C., Ollmann M., Kobayashi T., Abdel-Malek Z., Muller J., Vieira W.D., et al. Modulation of murine melanocyte function in vitro by agouti signal protein. EMBO J 16 (1997) 3544-3552
167. Newton R.A., Cook A.L., Roberts D.W., Leonard J.H., and Sturm R.A. Post-transcriptional regulation of melanin biosynthetic enzymes by cAMP and resveratrol in human melanocytes. J Invest Dermatol 127 (2007) 2216-2227
168. Loir B., Bouchard B., Morandini R., Del Marmol V., Deraemaecker R., Garcia-Borron J.C., et al. Immunoreactive alpha-melanotropin as an autocrine effector in human melanoma cells. Eur J Biochem 244 (1997) 923-930
169. Schauer E., Trautinger F., Kock A., Schwarz A., Bhardwaj R., Simon M., et al. Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J Clin Invest 93 (1994) 2258-2262
170. Sanchez Mas J., Gerritsen I., Hahmann C., Jimenez-Cervantes C., and Garcia-Borron J.C. Rate limiting factors in melanocortin 1 receptor signalling through the cAMP pathway. Pigment Cell Res 16 (2003) 540-547
171. Donatien P.D., Hunt G., Pieron C., Lunec J., Taieb A., and Thody A.J. The expression of functional MSH receptors on cultured human melanocytes. Arch Dermatol Res 284 (1992) 424-426
172. Garcia-Borron J.C., Sanchez-Laorden B.L., and Jimenez-Cervantes C. Melanocortin-1 receptor structure and functional regulation. Pigment Cell Res 18 (2005) 393-410
173. Siegrist W., Girard J., and Eberle A.N. Quantification of MSH receptors on mouse melanoma tissue by receptor autoradiography. J Receptor Res 11 (1991) 323-331
174. Mountjoy K.G. The human melanocyte stimulating hormone receptor has evolved to become "super-sensitive" to melanocortin peptides. Mol Cell Endocrinol 102 (1994) R7-R11
175. Abdel-Malek Z., Suzuki I., Tada A., Im S., and Akcali C. The melanocortin-1 receptor and human pigmentation. Ann N Y Acad Sci 885 (1999) 117-133
176. Jackson I.J., Budd P.S., Keighren M., and McKie L. Humanized MC1R transgenic mice reveal human specific receptor function. Hum Mol Genet 16 (2007) 2341-2348
177. Ozeki H., Ito S., Wakamatsu K., and Hirobe T. Chemical characterization of hair melanins in various coat-color mutants of mice. J Invest Dermatol 105 (1995) 361-366
178. Beaumont K.A., Shekar S.N., Cook A.L., Duffy D.L., and Sturm R.A. Red hair is the null phenotype of MC1R. Hum Mutat 29 (2008) E88-E94
179. Burchill S.A., Virden R., and Thody A.J. Regulation of tyrosinase synthesis and its processing in the hair follicular melanocytes of the mouse during eumelanogenesis and phaeomelanogenesis. J Invest Dermatol 93 (1989) 236-240
180. Burchill S.A., Ito S., and Thody A.J. Effects of melanocyte-stimulating hormone on tyrosinase expression and melanin synthesis in hair follicular melanocytes of the mouse. J Endocrinol 137 (1993) 189-195
181. Ito S. A chemist's view of melanogenesis. Pigment Cell Res 16 (2003) 230-236
182. Scott M.C., Wakamatsu K., Ito S., Kadekaro A.L., Kobayashi N., Groden J., et al. Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation. J Cell Sci 115 (2002) 2349-2355
183. Mountjoy K.G., Kong P.L., Taylor J.A., Willard D.H., and Wilkison W.O. Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells. Physiol Genomics 5 (2001) 11-19
184. Eves P., Haycock J., Layton C., Wagner M., Kemp H., Szabo M., et al. Anti-inflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cells. Br J Cancer 89 (2003) 2004-2015
185. Smith A.G., Luk N., Newton R.A., Roberts D.W., Sturm R.A., and Muscat G.E. Melanocortin-1 receptor signaling markedly induces the expression of the NR4A nuclear receptor subgroup in melanocytic cells. J Biol Chem 283 (2008) 12564-12570
186. Kim J.H., Kiefer L.L., Woychik R.P., Wilkison W.O., Truesdale A., Ittoop O., et al. Agouti regulation of intracellular calcium: role of melanocortin receptors. Am J Physiol Endocrinol Metab 35 (1997) E379-E384
187. Konda Y., Gantz I., DelValle J., Shimoto Y., Miwa H., and Yamada T. Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J Biol Chem 269 (1994) 13162-13166
188. Hoogduijn M.J., McGurk S., Smit N.P., Nibbering P.H., Ancans J., van der Laarse A., et al. Ligand-dependent activation of the melanocortin 5 receptor: cAMP production and ryanodine receptor-dependent elevations of [Ca(2+)](I). Biochem Biophys Res Commun 290 (2002) 844-850
189. Wachira S.J., Hughes-Darden C.A., Taylor C.V., Ochillo R., and Robinson T.J. Evidence for the interaction of protein kinase C and melanocortin 3-receptor signaling pathways. Neuropeptides 37 (2003) 201-210
190. Newman E.A., Chai B.X., Zhang W., Li J.Y., Ammori J.B., and Mulholland M.W. Activation of the melanocortin-4 receptor mobilizes intracellular free calcium in immortalized hypothalamic neurons. J Surg Res 132 (2006) 201-207
191. Kojima I., Kojima K., and Rasmussen H. Role of calcium and cAMP in the action of adrenocorticotropin on aldosterone secretion. J Biol Chem 260 (1985) 4248-4256
192. Dumaz N., and Marais R. Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft fur Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels. FEBS J 272 (2005) 3491-3504
193. Busca R., Abbe P., Mantoux F., Aberdam E., Peyssonnaux C., Eychene A., et al. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J 19 (2000) 2900-2910
194. Englaro W., Rezzonico R., Durand-Clement M., Lallemand D., Ortonne J.P., and Ballotti R. Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J Biol Chem 270 (1995) 24315-24320
195. Muller M., Obeyesekere M., Mills G.B., and Ram P.T. Network topology determines dynamics of the mammalian MAPK1,2 signaling network: bifan motif regulation of C-Raf and B-Raf isoforms by FGFR and MC1R. FASEB J 22 (2008) 1393-13403
196. Hemesath T.J., Price E.R., Takemoto C., Badalian T., and Fisher D.E. MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature 391 (1998) 298-301
197. Smalley K., and Eisen T. The involvement of p38 mitogen-activated protein kinase in the alpha-melanocyte stimulating hormone (alpha-MSH)-induced melanogenic and anti-proliferative effects in B16 murine melanoma cells. FEBS Lett 476 (2000) 198-202
198. Newton R.A., Roberts D.W., Leonard J.H., and Sturm R.A. Human melanocytes expressing MC1R variant alleles show impaired activation of multiple signaling pathways. Peptides 28 (2007) 2387-2396
199. Galibert M.D., Carreira S., and Goding C.R. The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced tyrosinase expression. EMBO J 20 (2001) 5022-5031
200. Corre S., Primot A., Sviderskaya E., Bennett D.C., Vaulont S., Goding C.R., et al. UV-induced expression of key component of the tanning process, the POMC and MC1R genes, is dependent on the p-38-activated upstream stimulating factor-1 (USF-1). J Biol Chem 279 (2004) 51226-51233
201. Siegrist W., Drozdz R., Cotti R., Willard D.H., Wilkison W.O., and Eberle A.N. Interactions of alpha-melanotropin and agouti on B16 melanoma cells: evidence for inverse agonism of agouti. J Recept Signal Transduct Res 17 (1997) 75-98
202. Le Pape E., Wakamatsu K., Ito S., Wolber R., and Hearing V.J. Regulation of eumelanin/pheomelanin synthesis and visible pigmentation in melanocytes by ligands of the melanocortin 1 receptor. Pigment Cell Melanoma Res 21 (2008) 477-486
203. Suzuki I., Tada A., Ollmann M.M., Barsh G.S., Im S., Lamoreux M.L., et al. Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin. J Invest Dermatol 108 (1997) 838-842
204. Healy E., Jordan S.A., Budd P.S., Suffolk R., Rees J.L., and Jackson I.J. Functional variation of MC1R alleles from red-haired individuals. Hum Mol Genet 10 (2001) 2397-2402
205. Kanetsky P.A., Swoyer J., Panossian S., Holmes R., Guerry D., and Rebbeck T.R. A polymorphism in the agouti signaling protein gene is associated with human pigmentation. Am J Hum Genet 70 (2002) 770-775
206. Voisey J., Kelly G., and van Daal A. Agouti signal protein regulation in human melanoma cells. Pigment Cell Res 16 (2003) 65-71
207. Voisey J., Box N.F., and van Daal A. A polymorphism study of the human Agouti gene and its association with MC1R. Pigment Cell Res 14 (2001) 264-267
208. Voisey J., Gomez-Cabrera Mdel C., Smit D.J., Leonard J.H., Sturm R.A., and van Daal A. A polymorphism in the agouti signalling protein (ASIP) is associated with decreased levels of mRNA. Pigment Cell Res 19 (2006) 226-231
209. Brown K.M., Macgregor S., Montgomery G.W., Craig D.W., Zhao Z.Z., Iyadurai K., et al. Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat Genet 40 (2008) 838-840
210. Le Pape E., Passeron T., Giubellino A., Valencia J.C., Wolber R., and Hearing V.J. Microarray analysis sheds light on the de-differentiating role of agouti signal protein in murine melanocytes via the Mc1r. Proc Natl Acad Sci USA (2009) doi:10.1073/pnas.0806753106
211. Ollmann M.M., Lamoreux M.L., Wilson B.D., and Barsh G.S. Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo. Genes Dev 12 (1998) 316-330
212. Candille S.I., Kaelin C.B., Cattanach B.M., Yu B., Thompson D.A., Nix M.A., et al. A {beta}-defensin mutation causes black coat color in domestic dogs. Science 318 (2007) 1418-1423
213. Kaelin C.B., Candille S.I., Yu B., Jackson P., Thompson D.A., Nix M.A., et al. New ligands for melanocortin receptors. Int J Obes 32 Suppl. 7 (2008) S19-S27
214. Park H.Y., Russakovsky V., Ao Y., Fernandez E., and Gilchrest B.A. Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C. Exp Cell Res 227 (1996) 70-79
215. Makova K., and Norton H. Worldwide polymorphism at the MC1R locus and normal pigmentation variation in humans. Peptides 26 (2005) 1901-1908
216. Wong T.H., and Rees J.L. The relation between melanocortin 1 receptor (MC1R) variation and the generation of phenotypic diversity in the cutaneous response to ultraviolet radiation. Peptides 26 (2005) 1965-1971
217. Gerstenblith M.R., Goldstein A.M., Fargnoli M.C., Peris K., and Landi M.T. Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat 28 (2007) 495-505
218. Raimondi S., Sera F., Gandini S., Iodice S., Caini S., Maisonneuve P., et al. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer 122 (2008) 2753-2760
219. Sturm R.A. Molecular genetics of human pigmentation diversity. Hum Mol Genet 18 (2009) R9-R17
220. Duffy D.L., Box N.F., Chen W., Palmer J.S., Montgomery G.W., James M.R., et al. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum Mol Genet 13 (2004) 447-461
221. Sturm R.A., Duffy D.L., Box N.F., Newton R.A., Shepherd A.G., Chen W., et al. Genetic association and cellular function of MC1R variant alleles in human pigmentation. Ann N Y Acad Sci 994 (2003) 348-358
222. Nakayama K., Soemantri A., Jin F., Dashnyam B., Ohtsuka R., Duanchang P., et al. Identification of novel functional variants of the melanocortin 1 receptor gene originated from Asians. Hum Genet 119 (2006) 322-330
223. Flanagan N., Healy E., Ray A., Philips S., Todd C., Jackson I.J., et al. Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation. Hum Mol Genet 9 (2000) 2531-2537
224. Healy E., Flannagan N., Ray A., Todd C., Jackson I.J., Matthews J.N., et al. Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair. Lancet 355 (2000) 1072-1073
225. Bastiaens M., ter Huurne J., Gruis N., Bergman W., Westendorp R., Vermeer B.J., et al. The melanocortin-1-receptor gene is the major freckle gene. Hum Mol Genet 10 (2001) 1701-1708
226. Palmer J.S., Duffy D.L., Box N.F., Aitken J.F., O'Gorman L.E., Green A.C., et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?. Am J Hum Genet 66 (2000) 176-186
227. Savage S.A., Gerstenblith M.R., Goldstein A.M., Mirabello L., Fargnoli M.C., Peris K., et al. Nucleotide diversity and population differentiation of the melanocortin 1 receptor gene, MC1R. BMC Genet 9 (2008) 31
228. Rana B.K., Hewett-Emmett D., Jin L., Chang B.H.J., Sambuughin N., Lin M., et al. High polymorphism at the human melanocortin 1 receptor locus. Genetics 151 (1999) 1547-1557
229. Harding R.M., Healy E., Ray A.J., Ellis N.S., Flanagan N., Todd C., et al. Evidence for variable selective pressures at MC1R. Am J Hum Genet 66 (2000) 1351-1361
230. Rees J.L. The melanocortin 1 receptor (MC1R): more than just red hair. Pigment Cell Res 13 (2000) 135-140
231. John P.R., Makova K., Li W.H., Jenkins T., and Ramsay M. DNA polymorphism and selection at the melanocortin-1 receptor gene in normally pigmented southern African individuals. Ann N Y Acad Sci 994 (2003) 299-306
232. Rogers A.R., Iltis D., and Wooding S. Genetic variation at the MC1R locus and the time since loss of body hair. Curr Anthropol 45 (2004) 105-108
233. Yao Y.G., Lu X.M., Luo H.R., Li W.H., and Zhang Y.P. Gene admixture in the silk road region of China: evidence from mtDNA and melanocortin 1 receptor polymorphism. Genes Genet Syst 75 (2000) 173-178
234. Peng S., Lu X.M., Luo H.R., Xiang-Yu J.G., and Zhang Y.P. Melanocortin-1 receptor gene variants in four Chinese ethnic populations. Cell Res 11 (2001) 81-84
235. Motokawa T., Kato T., Hashimoto Y., and Katagiri T. Effect of Val92Met and Arg163Gln variants of the MC1R gene on freckles and solar lentigines in Japanese. Pigment Cell Res 20 (2007) 140-143
236. Nachman M.W., Hoekstra H.E., and D'Agostino S.L. The genetic basis of adaptive melanism in pocket mice. Proc Natl Acad Sci USA 100 (2003) 5268-5273
237. Hoekstra H.E., Hirschmann R.J., Bundey R.A., Insel P.A., and Crossland J.P. A single amino acid mutation contributes to adaptive beach mouse color pattern. Science 313 (2006) 101-104
238. Rouzaud F., Martin J., Gallet P.F., Delourme D., Goulemot-Leger V., Amigues Y., et al. A first genotyping assay of French cattle breeds based on a new allele of the extension gene encoding the melanocortin-1 receptor (Mc1r). Genet Sel Evol 32 (2000) 511-520
239. Marklund L., Moller M.J., Sandberg K., and Andersson L. A missense mutation in the gene for melanocyte-stimulating hormone receptor (MC1R) is associated with the chestnut coat color in horses. Mamm Genome 7 (1996) 895-899
240. Vage D.I., Lu D., Klungland H., Lien S., Adalsteinsson S., and Cone R.D. A non-epistatic interaction of agouti and extension in the fox, Vulpes vulpes. Nat Genet 15 (1997) 311-315
241. Kijas J.M.H., Moller M., Plastow G., and Andersson L. A frameshift mutation in MC1R and a high frequency of somatic reversions cause black spotting in pigs. Genetics 158 (2001) 779
242. Newton J.M., Wilkie A.L., He L., Jordan S.A., Metallinos D.L., Holmes N.G., et al. Melanocortin 1 receptor variation in the domestic dog. Mamm Genome 11 (2000) 24-30
243. Ritland K., Newton C., and Marshall H.D. Inheritance and population structure of the white-phased "Kermode" black bear. Curr Biol 11 (2001) 1468-1472
244. Takeuchi S., Suzuki H., Yabuuchi M., and Takahashi S. A possible involvement of melanocortin 1-receptor in regulating feather color pigmentation in the chicken. Biochim Biophys Acta 1308 (1996) 164-168
245. Baiao P.C., Schreiber E., and Parker P.G. The genetic basis of the plumage polymorphism in red-footed boobies (Sula sula): a melanocortin-1 receptor (MC1R) analysis. J Heredity 98 (2007) 287-292
246. Gross J.B., Borowsky R., and Tabin C.J. A novel role for Mc1r in the parallel evolution of depigmentation in independent populations of the cavefish Astyanax mexicanus. PLoS Genet 5 (2009) e1000326
247. Lalueza-Fox C., Rompler H., Caramelli D., Staubert C., Catalano G., Hughes D., et al. A melanocortin 1 receptor allele suggests varying pigmentation among Neanderthals. Science 318 (2007) 1453-1455
248. Sturm R.A. A golden age of human pigmentation genetics. Trends Genet 22 (2006) 464-468
249. McEvoy B., Beleza S., and Shriver M.D. The genetic architecture of normal variation in human pigmentation: an evolutionary perspective and model. Hum Mol Genet 15 Spec. No. 2 (2006) R176-R181
250. Anno S., Abe T., and Yamamoto T. Interactions between SNP alleles at multiple loci contribute to skin color differences between caucasoid and mongoloid subjects. Int J Biol Sci 4 (2008) 81-86
251. Frandberg P.A., Doufexis M., Kapas S., and Chhajlani V. Human pigmentation phenotype: a point mutation generates nonfunctional MSH receptor. Biochem Biophys Res Commun 245 (1998) 490-492
252. Siegrist W., Stutz S., and Eberle A.N. Homologous and heterologous regulation of alpha-melanocyte-stimulating hormone receptors in human and mouse melanoma cell lines. Cancer Res 54 (1994) 2604-2610
253. Schioth H.B., Phillips S.R., Rudzish R., Birch-Machin M.A., Wikberg J.E., and Rees J.L. Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. Biochem Biophys Res Commun 260 (1999) 488-491
254. Robinson S.J., and Healy E. Human melanocortin 1 receptor (MC1R) gene variants alter melanoma cell growth and adhesion to extracellular matrix. Oncogene 21 (2002) 8037-8046
255. Ringholm A., Klovins J., Rudzish R., Phillips S., Rees J.L., and Schioth H.B. Pharmacological characterization of loss of function mutations of the human Melanocortin 1 Receptor that are associated with red hair. J Invest Dermatol 123 (2004) 917-923
256. Newton R.A., Smit S.E., Barnes C.C., Pedley J., Parsons P.G., and Sturm R.A. Activation of the cAMP pathway by variant human MC1R alleles expressed in HEK and in melanoma cells. Peptides 26 (2005) 1818-1824
257. Beaumont K.A., Newton R.A., Smit D.J., Leonard J.H., Stow J.L., and Sturm R.A. Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk. Hum Mol Genet 14 (2005) 2145-2154
258. Sanchez-Laorden B.L., Sanchez-Mas J., Turpin M.C., Garcia-Borron J.C., and Jimenez-Cervantes C. Variant amino acids in different domains of the human melanocortin 1 receptor impair cell surface expression. Cell Mol Biol (Noisy-le-Grand) 52 (2006) 39-46
259. Sanchez-Laorden B.L., Sanchez-Mas J., Martinez-Alonso E., Martinez-Menarguez J.A., Garcia-Borron C., and Jimenez-Cervantes C. Dimerization of the human melanocortin 1 receptor: functional consequences and dominant-negative effects. J Invest Dermatol 126 (2006) 172-181
260. Sanchez-Laorden B.L., Jimenez-Cervantes C., and Garcia-Borron J.C. Regulation of human melanocortin 1 receptor signaling and trafficking by Thr-308 and Ser-316 and its alteration in variant alleles associated with red hair and skin cancer. J Biol Chem 282 (2007) 3241-3251
261. Probst W.C., Snyder L.A., Schuster D.I., Brosius J., and Sealfon S.C. Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol 11 (1992) 1-20
262. Barak L.S., Menard L., Ferguson S.S., Colapietro A.M., and Caron M.G. The conserved seven-transmembrane sequence NP(X)2,3Y of the G-protein-coupled receptor superfamily regulates multiple properties of the beta 2-adrenergic receptor. Biochemistry 34 (1995) 15407-15414
263. Le Gouill C., Parent J.L., Rola-Pleszczynski M., and Stankova J. Structural and functional requirements for agonist-induced internalization of the human platelet-activating factor receptor. J Biol Chem 272 (1997) 21289-21295
264. Beaumont K.A., Shekar S.L., Newton R.A., James M.R., Stow J.L., Duffy D.L., et al. Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles. Hum Mol Genet 16 (2007) 2249-2260
265. Commo S.F., Gaillard O., Rees J.L., and Bernard B.A. Impact of homozygosity of R151C variant of MC1r in human hair follicle melanocytes. J Invest Dermatol 128 (2008) 1319-1322
266. Zhu S.Z., Wang S.Z., Hu J., and el-Fakahany E.E. An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor. Mol Pharmacol 45 (1994) 517-523
267. Arora K.K., Cheng Z., and Catt K.J. Mutations of the conserved DRS motif in the second intracellular loop of the gonadotropin-releasing hormone receptor affect expression, activation, and internalization. Mol Endocrinol 11 (1997) 1203-1212
268. Valverde P., Healy E., Sikkink S., Haldane F., Thody A.J., Carothers A., et al. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum Mol Genet 5 (1996) 1663-1666
269. Han J., Kraft P., Colditz G.A., Wong J., and Hunter D.J. Melanocortin 1 receptor variants and skin cancer risk. Int J Cancer 119 (2006) 1976-1984
270. Cook A.L., Chen W., Thurber A.E., Smit D.J., Smith A.G., Bladen T.G., et al. Analysis of cultured human melanocytes based on polymorphisms within the SLC45A2/MATP, SLC24A5/NCKX5, and OCA2/P loci. J Invest Dermatol 129 (2008) 392-405
271. Roberts D.W., Newton R.A., Leonard J.H., and Sturm R.A. Melanocytes expressing MC1R polymorphisms associated with red hair color have altered MSH-ligand activated pigmentary responses in coculture with keratinocytes. J Cell Physiol 215 (2008) 344-355
272. Sung C.H., Davenport C.M., and Nathans J. Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. Clustering of functional classes along the polypeptide chain. J Biol Chem 268 (1993) 26645-26649
273. Miranda K.C., Khromykh T., Christy P., Le T.L., Gottardi C.J., Yap A.S., et al. A dileucine motif targets E-cadherin to the basolateral cell surface in Madin-Darby canine kidney and LLC-PK1 epithelial cells. J Biol Chem 276 (2001) 22565-22572
274. Duvernay M.T., Filipeanu C.M., and Wu G. The regulatory mechanisms of export trafficking of G protein-coupled receptors. Cell Signal 17 (2005) 1457-1465
275. Sánchez-Laorden B.L., Herraiz C., Valencia J.C., Hearing V.J., Jiménez-Cervantes C., and García-Borrón J.C. Aberrant trafficking of human melanocortin 1 receptor variants associated with red hair and skin cancer: Steady-state retention of mutant forms in the proximal golgi. J Cell Physiol (2009) DOI: 10.1002/jcp.21804
276. Tao Y.X. Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Mol Cell Endocrinol 239 (2005) 1-14
277. Xu X., Thornwall M., Lundin L.G., and Chhajlani V. Val92Met variant of the melanocyte stimulating hormone receptor gene. Nat Genet 14 (1996) 384
278. Koppula S.V., Robbins L.S., Lu D., Baack E., White C.R., Swanson N.A., et al. Identification of common polymorphisms in the coding sequence of the human MSH receptor (MC1R) with possible biological effects. Hum Mutat 9 (1997) 30-36
279. Kanetsky P.A., Rebbeck T.R., Hummer A.J., Panossian S., Armstrong B.K., Kricker A., et al. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res 66 (2006) 9330-9337
280. Beaumont K.A. The molecular mechanism of MC1R association with skin cancer risk Phenotypes (2008), University of Queensland PhD thesis
281. Sanchez-Mas J., Hahmann C., Gerritsen I., Garcia-Borron J.C., and Jimenez-Cervantes C. Agonist-independent, high constitutive activity of the human melanocortin 1 receptor. Pigment Cell Res 17 (2004) 386-395
282. Zanna P.T., Sanchez-Laorden B.L., Perez-Oliva A.B., Turpin M.C., Herraiz C., Jimenez-Cervantes C., et al. Mechanism of dimerization of the human melanocortin 1 receptor. Biochem Biophys Res Commun 368 (2008) 211-216
283. Sanchez-Mas J., Guillo L.A., Zanna P., Jimenez-Cervantes C., and Garcia-Borron J.C. Role of G protein-coupled receptor kinases in the homologous desensitization of the human and mouse melanocortin 1 receptors. Mol Endocrinol 19 (2005) 1035-1048
284. Fredriksson R., Lagerstrom M.C., Lundin L.G., and Schioth H.B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63 (2003) 1256-1272
285. Gantz I., Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G., et al. Molecular cloning of a novel melanocortin receptor. J Biol Chem 268 (1993) 8246-8250
286. Roselli-Rehfuss L., Mountjoy K.G., Robbins L.S., Mortrud M.T., Low M.J., Tatro J.B., et al. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 90 (1993) 8856-8860
287. Gantz I., Miwa H., Konda Y., Shimoto Y., Tashiro T., Watson S.J., et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 268 (1993) 15174-15179
288. Chhajlani V., Muceniece R., and Wikberg J.E. Molecular cloning of a novel human melanocortin receptor. Biochem Biophys Res Commun 195 (1993) 866-873
289. Gantz I., Shimoto Y., Konda Y., Miwa H., Dickinson C.J., and Yamada T. Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem Biophys Res Commun 200 (1994) 1214-1220
290. Labbe O., Desarnaud F., Eggerickx D., Vassart G., and Parmentier M. Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry 33 (1994) 4543-4549
291. Xia Y., and Wikberg J.E. Localization of ACTH receptor mRNA by in situ hybridization in mouse adrenal gland. Cell Tissue Res 286 (1996) 63-68
292. Mountjoy K.G., Mortrud M.T., Low M.J., Simerly R.B., and Cone R.D. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8 (1994) 1298-1308
293. Chhajlani V. Distribution of cDNA for melanocortin receptor subtypes in human tissues. Biochem Mol Biol Int 38 (1996) 73-80
294. Gantz I., and Fong T.M. The melanocortin system. Am J Physiol Endocrinol Metab 284 (2003) E468-E474
295. Martin W.J., and MacIntyre D.E. Melanocortin receptors and erectile function. Eur Urol 45 (2004) 706-713
296. Ni X.P., Pearce D., Butler A.A., Cone R.D., and Humphreys M.H. Genetic disruption of gamma-melanocyte-stimulating hormone signaling leads to salt-sensitive hypertension in the mouse. J Clin Invest 111 (2003) 1251-1258
297. Humphreys M.H. Gamma-MSH, sodium metabolism, and salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 286 (2004) R417-R430
298. Chen W., Kelly M.A., Opitz-Araya X., Thomas R.E., Low M.J., and Cone R.D. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 91 (1997) 789-798
299. Morgan C., Thomas R.E., and Cone R.D. Melanocortin-5 receptor deficiency promotes defensive behavior in male mice. Horm Behav 45 (2004) 58-63
300. Morgan C., Thomas R.E., Ma W., Novotny M.V., and Cone R.D. Melanocortin-5 receptor deficiency reduces a pheromonal signal for aggression in male mice. Chem Senses 29 (2004) 111-115
301. Prusis P., Schioth H.B., Muceniece R., Herzyk P., Afshar M., Hubbard R.E., et al. Modeling of the three-dimensional structure of the human melanocortin 1 receptor, using an automated method and docking of a rigid cyclic melanocyte-stimulating hormone core peptide. J Mol Graph Model 15 (1997) 307-317 334
302. Tatusova T.A., and Madden T.L. BLAST 2 sequences, a new tool for comparing protein and nucleotide sequences. FEMS Microbiol Lett 174 (1999) 247-250
303. Kanetsky P.A., Ge F., Najarian D., Swoyer J., Panossian S., Schuchter L., et al. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach. Cancer Epidemiol Biomarkers Prev 13 (2004) 808-819
304. Govaerts C., Srinivasan S., Shapiro A., Zhang S., Picard F., Clement K., et al. Obesity-associated mutations in the melanocortin 4 receptor provide novel insights into its function. Peptides 26 (2005) 1909-1919
305. Lubrano-Berthelier C., Durand E., Dubern B., Shapiro A., Dazin P., Weill J., et al. Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. Hum Mol Genet 12 (2003) 145-153
306. Lubrano-Berthelier C., Cavazos M., Dubern B., Shapiro A., Stunff C.L., Zhang S., et al. Molecular genetics of human obesity-associated MC4R mutations. Ann N Y Acad Sci 994 (2003) 49-57
307. Xiang Z., Litherland S.A., Sorensen N.B., Proneth B., Wood M.S., Shaw A.M., et al. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist. Biochemistry 45 (2006) 7277-7288
308. Lubrano-Berthelier C., Dubern B., Lacorte J.M., Picard F., Shapiro A., Zhang S., et al. Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating. J Clin Endocrinol Metab 91 (2006) 1811-1818
309. Chan L.F., Clark A.J., and Metherell L.A. Familial glucocorticoid deficiency: advances in the molecular understanding of ACTH action. Horm Res 69 (2008) 75-82
310. Metherell L.A., Chapple J.P., Cooray S., David A., Becker C., Ruschendorf F., et al. Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat Genet 37 (2005) 166-170
311. Lee Y.S., Poh L.K., and Loke K.Y. A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J Clin Endocrinol Metab 87 (2002) 1423-1426
312. Schalin-Jantti C., Valli-Jaakola K., Oksanen L., Martelin E., Laitinen K., Krusius T., et al. Melanocortin-3-receptor gene variants in morbid obesity. Int J Obes Relat Metab Disord 27 (2003) 70-74
313. Tao Y.X. Functional characterization of novel melanocortin-3 receptor mutations identified from obese subjects. Biochim Biophys Acta 1772 (2007) 1167-1174
314. Chagnon Y.C., Chen W.J., Perusse L., Chagnon M., Nadeau A., Wilkison W.O., et al. Linkage and association studies between the melanocortin receptors 4 and 5 genes and obesity-related phenotypes in the Quebec family study. Mol Med 3 (1997) 663-673
315. Healy E. Neanderthal man's MC1R plays fair. Pigment Cell Melanoma Res 21 (2008) 340-341
316. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 (2000) 739-745
317. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318 (2007) 1258-1265
318. Rasmussen S.G., Choi H.J., Rosenbaum D.M., Kobilka T.S., Thian F.S., Edwards P.C., et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450 (2007) 383-387
319. Sun H., and Fry D. Molecular modeling of melanocortin receptors. Curr Top Med Chem 7 (2007) 1042-1051
320. Savarese T.M., and Fraser C.M. In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem J 283 (1992) 1-19
321. Rovati G.E., Capra V., and Neubig R.R. The highly conserved DRY motif of class A G protein-coupled receptors: beyond the ground state. Mol Pharmacol 71 (2007) 959-964
322. Barak L.S., Oakley R.H., Laporte S.A., and Caron M.G. Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus. Proc Natl Acad Sci USA 98 (2001) 93-98
323. Costa E.M., Bedecarrats G.Y., Mendonca B.B., Arnhold I.J., Kaiser U.B., and Latronico A.C. Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction. J Clin Endocrinol Metab 86 (2001) 2680-2686
324. Berchiche Y.A., Chow K.Y., Lagane B., Leduc M., Percherancier Y., Fujii N., et al. Direct assessment of CXCR4 mutant conformations reveals complex link between receptor structure and G(alpha)(i) activation. J Biol Chem 282 (2007) 5111-5115
325. Elias L.L., Huebner A., Pullinger G.D., Mirtella A., and Clark A.J. Functional characterization of naturally occurring mutations of the human adrenocorticotropin receptor: poor correlation of phenotype and genotype. J Clin Endocrinol Metab 84 (1999) 2766-2770
326. Yamano Y., Kamon R., Yoshimizu T., Toda Y., Oshida Y., Chaki S., et al. The role of the DRY motif of human MC4R for receptor activation. Biosci Biotechnol Biochem 68 (2004) 1369-1371
327. Ross E.M., Maguire M.E., Sturgill T.W., Biltonen R.L., and Gilman A.G. Relationship between the beta-adrenergic receptor and adenylate cyclase. J Biol Chem 252 (1977) 5761-5775
328. Johnson M.S., Robertson D.N., Holland P.J., Lutz E.M., and Mitchell R. Role of the conserved NPxxY motif of the 5-HT2A receptor in determining selective interaction with isoforms of ADP-ribosylation factor (ARF). Cell Signal 18 (2006) 1793-1800
329. Bhattacharya M., Babwah A.V., and Ferguson S.S. Small GTP-binding protein-coupled receptors. Biochem Soc Trans 32 (2004) 1040-1044
330. Houndolo T., Boulay P.L., and Claing A. G protein-coupled receptor endocytosis in ADP-ribosylation factor 6-depleted cells. J Biol Chem 280 (2005) 5598-5604
331. Donaldson J.G. Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane. J Biol Chem 278 (2003) 41573-41576
332. Kim K.S., Reecy J.M., Hsu W.H., Anderson L.L., and Rothschild M.F. Functional and phylogenetic analyses of a melanocortin-4 receptor mutation in domestic pigs. Domest Anim Endocrinol 26 (2004) 75-86
333. Fan Z.C., Sartin J.L., and Tao Y.X. Pharmacological analyses of two naturally occurring porcine melanocortin-4 receptor mutations in domestic pigs. Domest Anim Endocrinol 34 (2008) 383-390
334. Ellgaard L., and Helenius A. Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 4 (2003) 181-191
335. Frandberg P.A., Doufexis M., Kapas S., and Chhajlani V. Amino acid residues in third intracellular loop of melanocortin 1 receptor are involved in G-protein coupling. Biochem Mol Biol Int 46 (1998) 913-922
336. Sanchez Mas J., Olivares Sanchez C., Ghanem G., Haycock J., Lozano Teruel J.A., Garcia-Borron J.C., et al. Loss-of-function variants of the human melanocortin-1 receptor gene in melanoma cells define structural determinants of receptor function. Eur J Biochem 269 (2002) 6133-6141
337. Schioth H.B., Muceniece R., Szardenings M., Prusis P., Lindeberg G., Sharma S.D., et al. Characterisation of D117A and H260A mutations in the melanocortin 1 receptor. Mol Cell Endocrinol 126 (1997) 213-219
338. Frandberg P.A., Muceniece R., Prusis P., Wikberg J., and Chhajlani V. Evidence for alternate points of attachment for alpha-MSH and its stereoisomer [Nle4, D-Phe7]-alpha-MSH at the melanocortin-1 receptor. Biochem Biophys Res Commun 202 (1994) 1266-1271
339. Yang Y.K., Dickinson C., HaskellLuevano C., and Gantz I. Molecular basis for the interaction of Nle(4), D-Phe(7) melanocyte stimulating hormone with the human melanocortin-1 receptor (melanocyte alpha-MSH receptor). J Biol Chem 272 (1997) 23000-23010
340. Schioth H.B., Yook P., Muceniece R., Wikberg J.E., and Szardenings M. Chimeric melanocortin MC1 and MC3 receptors: identification of domains participating in binding of melanocyte-stimulating hormone peptides. Mol Pharmacol 54 (1998) 154-161
341. Chhajlani V., Xu X., Blauw J., and Sudarshi S. Identification of ligand binding residues in extracellular loops of the melanocortin 1 receptor. Biochem Biophys Res Commun 219 (1996) 521-525
342. Pitcher J.A., Freedman N.J., and Lefkowitz R.J. G protein-coupled receptor kinases. Annu Rev Biochem 67 (1998) 653-692
343. Premont R.T., and Gainetdinov R.R. Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol 69 (2007) 511-534
344. Wong W., and Minchin R.F. Binding and internalization of the melanocyte stimulating hormone receptor ligand [Nle4, D-Phe7] alpha-MSH in B16 melanoma cells. Int J Biochem Cell Biol 28 (1996) 1223-1232
345. Froidevaux S., and Eberle A.N. Homologous regulation of melanocortin-1 receptor (MC1R) expression in melanoma tumor cells in vivo. J Recept Signal Transduct Res 22 (2002) 111-121
346. Ferguson S.S. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53 (2001) 1-24
347. Ding X.Q., Rao R.V., Kuntz S.M., Holicky E.L., and Miller L.J. Impaired resensitization and recycling of the cholecystokinin receptor by co-expression of its second intracellular loop. Mol Pharmacol 58 (2000) 1424-1433
348. Pawelek J.M., Chakraborty A.K., Osber M.P., Orlow S.J., Min K.K., Rosenzweig K.E., et al. Molecular cascades in UV-induced melanogenesis: a central role for melanotropins?. Pigment Cell Res 5 (1992) 348-356
349. Peters E.M., Tobin D.J., Seidah N.G., and Schallreuter K.U. Pro-opiomelanocortin-related peptides, prohormone convertases 1 and 2 and the regulatory peptide 7B2 are present in melanosomes of human melanocytes. J Invest Dermatol 114 (2000) 430-437
350. Tapia J.C.D., Bagutti C., Cotti R., and Eberle A.N. Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene. J Cell Sci 109 (1996) 2023-2030
351. Krude H., Biebermann H., Luck W., Horn R., Brabant G., and Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19 (1998) 155-157
352. Hoiom V., Tuominen R., Kaller M., Linden D., Ahmadian A., Mansson-Brahme E., et al. MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters. Pigment Cell Melanoma Res 22 (2009) 196-204
353. Yaswen L., Diehl N., Brennan M.B., and Hochgeschwender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5 (1999) 1066-1070
354. Clement K., Dubern B., Mencarelli M., Czernichow P., Ito S., Wakamatsu K., et al. Unexpected endocrine features and normal pigmentation in a young adult patient carrying a novel homozygous mutation in the POMC gene. J Clin Endocrinol Metab 93 (2008) 4955-4962
355. Overton M.C., and Blumer K.J. G-protein-coupled receptors function as oligomers in vivo. Curr Biol 10 (2000) 341-344
356. Bai M. Dimerization of G-protein-coupled receptors: roles in signal transduction. Cell Signalling 16 (2004) 175-186
357. Bulenger S., Marullo S., and Bouvier M. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol Sci 26 (2005) 131-137
358. Gurevich V.V., and Gurevich E.V. How and why do GPCRs dimerize?. Trends Pharmacol Sci 29 (2008) 234-240
359. Mandrika I., Petrovska R., and Wikberg J. Melanocortin receptors form constitutive homo- and heterodimers. Biochem Biophys Res Commun 326 (2005) 349-354
360. Biebermann H., Krude H., Elsner A., Chubanov V., Gudermann T., and Gruters A. Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. Diabetes 52 (2003) 2984-2988
361. Abdel-Malek Z.A. Melanocortin receptors: their functions and regulation by physiological agonists and antagonists. Cell Mol Life Sci 58 (2001) 434-441
362. Scott M.C., Suzuki I., and Abdel-Malek Z.A. Regulation of the human melanocortin 1 receptor expression in epidermal melanocytes by paracrine and endocrine factors and by ultraviolet radiation. Pigment Cell Res 15 (2002) 433-439
363. Rouzaud F., Annereau J.P., Valencia J.C., Costin G.E., and Hearing V.J. Regulation of melanocortin 1 receptor expression at the mRNA and protein levels by its natural agonist and antagonist. FASEB J 17 (2003) 2154-2156
364. Moro O., Ideta R., and Ifuku O. Characterization of the promoter region of the human melanocortin-1 receptor (MC1R) gene. Biochem Biophys Res Commun 262 (1999) 452-460
365. Smith A.G., Box N.F., Marks L.H., Chen W., Smit D.J., Wyeth J.R., et al. The human melanocortin-1 receptor locus: analysis of transcription unit, locus polymorphism and haplotype evolution. Gene 281 (2001) 81
366. Funasaka Y., Chakraborty A.K., Hayashi Y., Komoto M., Ohashi A., Nagahama M., et al. Modulation of melanocyte-stimulating hormone receptor expression on normal human melanocytes: evidence for a regulatory role of ultraviolet B, interleukin-1alpha, interleukin-1beta, endothelin-1 and tumour necrosis factor-alpha. Br J Dermatol 139 (1998) 216-224
367. Jimenez-Cervantes C., Germer S., Gonzalez P., Sanchez J., Sanchez C.O., and Garcia-Borron J.C. Thr40 and Met122 are new partial loss-of-function natural mutations of the human melanocortin 1 receptor. FEBS Lett 508 (2001) 44-48
368. Hanson K.M., and Clegg R.M. Observation and quantification of ultraviolet-induced reactive oxygen species in ex vivo human skin. Photochem Photobiol 76 (2002) 57-63
369. Jimenez-Cervantes C., Martinez-Esparza M., Perez C., Daum N., Solano F., and Garcia-Borron J.C. Inhibition of melanogenesis in response to oxidative stress: transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor. J Cell Sci 114 (2001) 2335-2344
370. van der Velden P.A., Sandkuijl L.A., Bergman W., Pavel S., van Mourik L., Frants R.R., et al. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet 69 (2001) 774-779
371. Kennedy C., ter Huurne J., Berkhout M., Gruis N., Bastiaens M., Bergman W., et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 117 (2001) 294-300
372. Bastiaens M.T., ter Huurne J.A.C., Kielich C., Gruis N.A., Westendorp R.G.J., Vermeer B.J., et al. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet 68 (2001) 884-894
373. Box N.F., Duffy D.L., Irving R.E., Russell A., Chen W., Griffiths L.R., et al. Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol 116 (2001) 224
374. Matichard E., Verpillat P., Meziani R., Gerard B., Descamps V., Legroux E., et al. Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet 41 (2004) e13
375. Landi M.T., Kanetsky P.A., Tsang S., Gold B., Munroe D., Rebbeck T., et al. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst 97 (2005) 998-1007
376. Scherer D., Bermejo J.L., Rudnai P., Gurzau E., Koppova K., Hemminki K., et al. MC1R variants associated susceptibility to basal cell carcinoma of skin: interaction with host factors and XRCC3 polymorphism. Int J Cancer 122 (2008) 1787-1793
377. Stratigos A.J., Dimisianos G., Nikolaou V., Poulou M., Sypsa V., Stefanaki I., et al. Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population. J Invest Dermatol 126 (2006) 1842-1849
378. Liboutet M., Portela M., Delestaing G., Vilmer C., Dupin N., Gorin I., et al. MC1R and PTCH gene polymorphism in French patients with basal cell carcinomas. J Invest Dermatol 126 (2006) 1510-1517
379. Landi M.T., Bauer J., Pfeiffer R.M., Elder D.E., Hulley B., Minghetti P., et al. MC1R germline variants confer risk for BRAF-mutant melanoma. Science 313 (2006) 521-522
380. Hauser J.E., Kadekaro A.L., Kavanagh R.J., Wakamatsu K., Terzieva S., Schwemberger S., et al. Melanin content and MC1R function independently affect UVR-induced DNA damage in cultured human melanocytes. Pigment Cell Res 19 (2006) 303-314
381. Garcin G., Douki T., Stoebner P.E., Guesnet J., Guezennec A., Martinez J., et al. Cell surface expression of melanocortin-1 receptor on HaCaT keratinocytes and alpha-melanocortin stimulation do not affect the formation and repair of UVB-induced DNA photoproducts. Photochem Photobiol Sci 6 (2007) 585-593
382. Lunec J., Pieron C., and Thody A.J. MSH receptor expression and the relationship to melanogenesis and metastatic activity in B16 melanoma. Melanoma Res 2 (1992) 5-12
383. Suzuki I., Cone R.D., Im S., Nordlund J., and AbdelMalek Z.A. Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 137 (1996) 1627-1633
384. Bohm M., Wolff I., Scholzen T.E., Robinson S.J., Healy E., Luger T.A., et al. alpha-Melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem 280 (2005) 5795-5802
385. Kadekaro A.L., Kavanagh R., Kanto H., Terzieva S., Hauser J., Kobayashi N., et al. alpha-Melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res 65 (2005) 4292-4299
386. Pavey S., and Gabrielli B. alpha-melanocyte stimulating hormone potentiates p16/CDKN2A expression in human skin after ultraviolet irradiation. Cancer Res 62 (2002) 875-880
387. Box N.F., Duffy D.L., Chen W., Stark M., Martin N.G., Sturm R.A., et al. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 69 (2001) 765-773
388. Chaudru V., Laud K., Avril M.F., Miniere A., Chompret A., Bressac-de Paillerets B., et al. Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees. Cancer Epidemiol Biomarkers Prev 14 (2005) 2384-2390
389. Goldstein A.M., Landi M.T., Tsang S., Fraser M.C., Munroe D.J., and Tucker M.A. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. Cancer Epidemiol Biomarkers Prev 14 (2005) 2208-2212
390. Debniak T., Scott R., Masojc B., Serrano-Fernandez P., Huzarski T., Byrski T., et al. MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk. Int J Cancer 119 (2006) 2597-2602
391. Goldstein A.M., Chaudru V., Ghiorzo P., Badenas C., Malvehy J., Pastorino L., et al. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries. Int J Cancer 121 (2007) 825-831
392. Eliason M.J., Hansen C.B., Hart M., Porter-Gill P., Chen W., Sturm R.A., et al. Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation. Arch Dermatol 143 (2007) 1409-1412
393. Pastorino L., Bonelli L., Ghiorzo P., Queirolo P., Battistuzzi L., Balleari E., et al. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma. Pigment Cell Melanoma Res 21 (2008) 700-709
394. Hacker E., and Hayward N.K. Germline MC1R variants and BRAF mutant melanoma. J Invest Dermatol 128 (2008) 2354-2356
395. Fargnoli M.C., Pike K., Pfeiffer R.M., Tsang S., Rozenblum E., Munroe D.J., et al. MC1R variants increase risk of melanomas harboring BRAF mutations. J Invest Dermatol 128 (2008) 2485-2490
396. Kim R.D., Curtin J.A., and Bastian B.C. Lack of somatic alterations of MC1R in primary melanoma. Pigment Cell Melanoma Res 21 (2008) 579-582
397. Motokawa T., Kato T., Hashimoto Y., Takimoto H., Yamamoto H., and Katagiri T. Polymorphism patterns in the promoter region of the MC1R gene are associated with development of freckles and solar lentigines. J Invest Dermatol 128 (2008) 1588-1591
398. Viros A., Fridlyand J., Bauer J., Lasithiotakis K., Garbe C., Pinkel D., et al. Improving melanoma classification by integrating genetic and morphologic features. PLoS Med 5 (2008) e120
399. Zalaudek I., Meiklejohn W., Argenziano G., Thurber A.E., and Sturm R.A. "White" nevi and "Red" melanomas: association with the RHC phenotype of the MC1R gene. J Invest Dermatol 129 (2009) 1305-1307
400. Cuellar F., Puig S., Kolm I., Puig-Butille J., Zaballos P., Marti-Laborda R., et al. Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers. Br J Dermatol 160 (2009) 48-53
401. Brzoska T., Luger T.A., Maaser C., Abels C., and Bohm M. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev 29 (2008) 581-602
402. Li D., and Taylor A.W. Diminishment of {alpha}-MSH anti-inflammatory activity in MC1r siRNA-transfected RAW264.7 macrophages. J Leukoc Biol 84 (2008) 191-198
403. Manna S.K., and Aggarwal B.B. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J Immunol 161 (1998) 2873-2880
404. Catania A., Gatti S., Colombo G., and Lipton J.M. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 56 (2004) 1-29
405. Mogil J.S., Ritchie J., Smith S.B., Strasburg K., Kaplan L., Wallace M.R., et al. Melanocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humans. J Med Genet 42 (2005) 583-587
406. Mogil J.S., Wilson S.G., Chesler E.J., Rankin A.L., Nemmani K.V., Lariviere W.R., et al. The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proc Natl Acad Sci USA 100 (2003) 4867-4872
407. Xia Y., Wikberg J.E., and Chhajlani V. Expression of melanocortin 1 receptor in periaqueductal gray matter. NeuroReport 6 (1995) 2193-2196
408. Partridge J.M., Weatherby S.J., Woolmore J.A., Highland D.J., Fryer A.A., Mann C.L., et al. Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes. Neurology 62 (2004) 2323-2325
409. Dwyer T., van der Mei I., Ponsonby A.L., Taylor B.V., Stankovich J., McKay J.D., et al. Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis. Neurology 71 (2008) 583-589
410. Szell M., Baltas E., Bodai L., Bata-Csorgo Z., Nagy N., Dallos A., et al. The Arg160Trp allele of melanocortin-1 receptor gene might protect against vitiligo. Photochem Photobiol 84 (2008) 565-571
411. Edwards S.W., Tan C.M., and Limbird L.E. Localization of G-protein-coupled receptors in health and disease. Trends Pharmacol Sci 21 (2000) 304-308
412. Tao Y.X. Inactivating mutations of G protein-coupled receptors and diseases: structure-function insights and therapeutic implications. Pharmacol Ther 111 (2006) 949-973
413. Brown C.R., Hong-Brown L.Q., Biwersi J., Verkman A.S., and Welch W.J. Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperones 1 (1996) 117-125
414. Sato S., Ward C.L., Krouse M.E., Wine J.J., and Kopito R.R. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J Biol Chem 271 (1996) 635-638
415. Robben J.H., Sze M., Knoers N.V., and Deen P.M. Rescue of vasopressin v2 receptor mutants by chemical chaperones: specificity and mechanism. Mol Biol Cell 17 (2006) 379-386
416. Welch W.J., and Brown C.R. Influence of molecular and chemical chaperones on protein folding. Cell Stress Chaperones 1 (1996) 109-115
417. Denning G.M., Anderson M.P., Amara J.F., Marshall J., Smith A.E., and Welsh M.J. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358 (1992) 761-764
418. Michalovitz D., Halevy O., and Oren M. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62 (1990) 671-680
419. King R.A., Townsend D., Oetting W., Summers C.G., Olds D.P., White J.G., et al. Temperature-sensitive tyrosinase associated with peripheral pigmentation in oculocutaneous albinism. J Clin Invest 87 (1991) 1046-1053
420. Toyofuku K., Wada I., Spritz R.A., and Hearing V.J. The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation. Biochem J 355 (2001) 259-269
421. Jaquette J., and Segaloff D.L. Temperature sensitivity of some mutants of the lutropin/choriogonadotropin receptor. Endocrinology 138 (1997) 85-91
422. Tan C.M., Nickols H.H., and Limbird L.E. Appropriate polarization following pharmacological rescue of V2 vasopressin receptors encoded by X-linked nephrogenic diabetes insipidus alleles involves a conformation of the receptor that also attains mature glycosylation. J Biol Chem 278 (2003) 35678-35686
423. Gelman M.S., and Kopito R.R. Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis. J Clin Invest 110 (2002) 1591-1597
424. Bernier V., Bichet D.G., and Bouvier M. Pharmacological chaperone action on G-protein-coupled receptors. Curr Opin Pharmacol 4 (2004) 528-533
425. Morello J.P., Salahpour A., Laperriere A., Bernier V., Arthus M.F., Lonergan M., et al. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest 105 (2000) 887-895
426. Ulloa-Aguirre A., Janovick J.A., Leanos-Miranda A., and Conn P.M. Misrouted cell surface receptors as a novel disease aetiology and potential therapeutic target: the case of hypogonadotropic hypogonadism due to gonadotropin-releasing hormone resistance. Expert Opin Ther Targets 7 (2003) 175-185
427. Brothers S.P., Cornea A., Janovick J.A., and Conn P.M. Human loss-of-function gonadotropin-releasing hormone receptor mutants retain wild-type receptors in the endoplasmic reticulum: molecular basis of the dominant-negative effect. Mol Endocrinol 18 (2004) 1787-1797
428. Petaja-Repo U.E., Hogue M., Bhalla S., Laperriere A., Morello J.P., and Bouvier M. Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation. EMBO J 21 (2002) 1628-1637
429. Janovick J.A., Maya-Nunez G., and Conn P.M. Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target. J Clin Endocrinol Metab 87 (2002) 3255-3262
430. Agar N., and Young A.R. Melanogenesis: a photoprotective response to DNA damage?. Mutat Res 571 (2005) 121-132
431. Barnetson R.S., Ooi T.K., Zhuang L., Halliday G.M., Reid C.M., Walker P.C., et al. [Nle4-D-Phe7]-alpha-melanocyte-stimulating hormone significantly increased pigmentation and decreased UV damage in fair-skinned Caucasian volunteers. J Invest Dermatol 126 (2006) 1869-1878
432. D'Orazio J.A., Nobuhisa T., Cui R., Arya M., Spry M., Wakamatsu K., et al. Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning. Nature 443 (2006) 340-344
433. Spry M.L., Vanover J.C., Scott T., Abona-Ama O., Wakamatsu K., Ito S., et al. Prolonged treatment of fair-skinned mice with topical forskolin causes persistent tanning and UV protection. Pigment Cell Melanoma Res 22 (2009) 219-229
434. Bernier V., Morello J.P., Zarruk A., Debrand N., Salahpour A., Lonergan M., et al. Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 17 (2006) 232-243
435. Dwyer T., Stankovich J.M., Blizzard L., FitzGerald L.M., Dickinson J.L., Reilly A., et al. Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype?. Am J Epidemiol 159 (2004) 826-833
436. Brudnik U., Branicki W., Wojas-Pelc A., and Kanas P. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A > G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population. Exp Dermatol 18 (2008) 167-174
437. F-de-Misa R., Hernandez-Jimenez J.G., Carretero Hernandez G., Perez-Mendez L., Aguirre-Jaime A., Flores C., et al. The D84E variant of the alpha-MSH receptor 1 gene is associated with cutaneous malignant melanoma early onset. J Dermatol Sci 52 (2008) 186-192
438. Fernandez L., Milne R., Bravo J., Lopez J., Aviles J., Longo M., et al. MC1R: three novel variants identified in a malignant melanoma association study in the Spanish population. Carcinogenesis 28 (2007) 1659-1664
439. Mossner R., Anders N., Konig I.R., Kruger U., Schmidt D., Berking C., et al. Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma. Arch Dermatol Res 298 (2007) 371-379
440. Fargnoli M.C., Altobelli E., Keller G., Chimenti S., Hofler H., and Peris K. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study. Melanoma Res 16 (2006) 175-182